P

Purple Biotech Ltd
TASE:PPBT

Watchlist Manager
Purple Biotech Ltd
TASE:PPBT
Watchlist
Price: 4.1 ILS Market Closed
Market Cap: 21.2m ILS

Intrinsic Value

PPBT's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one PPBT stock under the Base Case scenario is 4.63 ILS. Compared to the current market price of 4.1 ILS, Purple Biotech Ltd is Undervalued by 11%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PPBT Intrinsic Value
4.63 ILS
Undervaluation 11%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation History
Purple Biotech Ltd

Valuation History Unavailable

Historical valuation for PPBT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare PPBT to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PPBT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Purple Biotech Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Purple Biotech Ltd

Current Assets 7.5m
Cash & Short-Term Investments 7.1m
Other Current Assets 428k
Non-Current Assets 28.1m
PP&E 237k
Intangibles 27.8m
Efficiency

Free Cash Flow Analysis
Purple Biotech Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Purple Biotech Ltd

Revenue
0 USD
Operating Expenses
-8m USD
Operating Income
-8m USD
Other Expenses
4.1m USD
Net Income
-3.9m USD
Fundamental Scores

PPBT Profitability Score
Profitability Due Diligence

Purple Biotech Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

32/100
Profitability
Score

Purple Biotech Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

PPBT Solvency Score
Solvency Due Diligence

Purple Biotech Ltd's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Low Altman Z-Score
47/100
Solvency
Score

Purple Biotech Ltd's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PPBT Price Targets Summary
Purple Biotech Ltd

There are no price targets for PPBT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PPBT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PPBT stock?

The intrinsic value of one PPBT stock under the Base Case scenario is 4.63 ILS.

Is PPBT stock undervalued or overvalued?

Compared to the current market price of 4.1 ILS, Purple Biotech Ltd is Undervalued by 11%.

Back to Top